EN
HI

REMUS PHARMACEUTICALS L Share price

REMUS

MiscellaneousSmall

2219.95

43.95 (2.02%)
NSE
BSE
Last updated on 16 May, 2025 | 15:27 IST
BUYSELL
Today's High

2279.00

Today's Low

2120.00

52 Week Low

1785.10

52 Week High

8699.00

The current prices are delayed, login to your account for live prices

Remus Pharmaceuticals Chart

REMUS PHARMACEUTICALS L Fundamentals

P/E Ratio

77.34

P/B Ratio

15.04

Div. Yield

0.07

Sector P/E

38.7

Sector P/B

1.46

Sec. Div. Yield

4.44

REMUS PHARMACEUTICALS L Resistance and Support

Pivot 2144.67

Resistance

First Resistance

2219.34

Second Resistance

2262.67

Third Resistance

2337.34

Support

First Support

2101.34

Second Support

2026.67

Third Support

1983.34

REMUS PHARMACEUTICALS L Futures & Options

Data Not Found

REMUS PHARMACEUTICALS L Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    70.84%

    Mutual Fund

    0%

    Insurance

    0%

    Foreign Institutional Investors

    3.16%

    Domestic Institutional Investors

    0.77%

    Retail

    25.22%

    Others

    0.01%

    Total Promoters
    MAR '24
    70.6%
    SEP '24
    70.84%

    REMUS PHARMACEUTICALS L Corporate Actions

    DateAgenda
    2025-05-17Audited Results
    DateEvent TypeAgenda
    2025-05-17Board MeetingAudited Results

    REMUS PHARMACEUTICALS L News

    No Data Found

    About REMUS PHARMACEUTICALS L AboutThe

    NSE : 16154  
    BSE : 210352  
    ISIN : INE0O5T01011  

    The Company was originally incorporated as ‘Remus Pharmaceuticals Private Limited’ as a private limited company under the provisions of the Companies Act 2013 vide Certificate of Incorporation dated September 21 2015 issued by the Assistant Registrar of Companies Gujarat. Later on pursuant to a special resolution passed by the shareholders in the Extra-Ordinary General Meeting held on January 02 2023 the Company was converted from a private limited company to public limited company and consequently the name of the Company was changed to “Remus Pharmaceuticals Limited” and a fresh certificate of incorporation dated January 06 2023 was issued to the Company by the Registrar of Companies Ahmedabad. The Corporate Identification Number of the Company is U24232GJ2015PLC084536.The Promoters Mr. Arpit Deepakkumar Shah Ms. Roma Vinodbhai Shah and Mr. Swapnil Jatinbhai Shah are associated with the company since incorporation. Mrs. Anar Swapnil Shah joined the company since March 2020. In this dynamic and extremely competitive business environment we have developed a diversified business model. the promoters have a combined experience of more than 36 years in the pharmaceutical industry. Driven by the passion for building an integrated pharmaceutical company backed by their experience the Promoters have been the pillars of the Company's growth and have built a strong value system for the Company. With their enriching experience and progressive thinking we aim to continue to grow in the pharmaceutical industry.The company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. the company also deals in API (Active Pharmaceutical Ingredient). We also provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network the clients are spread in more than 20 countries. We look forward to form long lasting relationships that enhance the lives of the patients.The Company is majorly engrossed in the pharmaceutical business involving marketing trading and distribution of wide range of pharmaceutical finished formulations and products. Depending upon business requirments we get finished pharmacuetical formulations manufactured on loan license or contract manufacturing. Such manufacturing is on principle to principle basis. We have the presence through registered and/or under registration products in countries namely Bhutan Bolivia Chile Costa Rica Cuba Dominican Republic Ecuador El Salvador Guatemala Honduras Jamaica Kuwait Madagascar Malaysia Hong kong Myanmar Panama Trinidad and Tobago Uzbekistan Venezuela Vietnam. We deal in drug forms like Capsules Cream Eye Drops Gel Infusion Inhalation Inhaler Injection Nail Lacquer Nasal Solution Nasal Spray Nebuliser Ointment Ophthalmic Oral Gel Oral Solution Oral Suspension Sachet Suspension Tablet.The product portfolio consists of 429 products as on January 31 2023. We operate under different brand names across the globe. As on January 31 2023 we have 295 products registered in total 13 countries. As on January 31 2023 total 134 products are under process of registration in 16 countries which shall boost the growth of the company. The product portfolio comprises of vide range of therapeutic drugs namely ACE inhibitors Analgesic anaesthetic Antiulcer Anti angiogenic Anti Erectile Dysfunction Anti fibrinolytic Anti histamine Anti-inflammatory Anti-ulcer Anti-acne Antianxiety Antiarrhythmic antiarrhythmic agent Antibiotic Antibiotic Anticancer Anticholinergics Anticoagulant Anticonvulsant Antidepressant Antidiabetic Antidiuretics Antiemetics Antifungal Anti-gastric Antihistaminic Antihypertensive Antimalarial Antioxidants Antiparasitic Antiprotozoal Antipsychotic Antipyretic Antiretroviral Antiretrovirals Anti-seizure Antispasmodic Anti-vertigo Antiviral Asthma Avitaminosis Beta blocker Carcinoid tumours Chronic Obstructive Pulmonary Disease CNS stimulants Contrast Reagent Corticosteroids Corticosteroids Dermatology Hyperprolactinemia Immuno-suppressive Iron chelator (binder) Iron deficiency Menopausal hormone therapy Mucolytic Nasal decongestants non-depolarizing neuromuscular blocker NSAIDs Ocular-hypertension Opioid Antagonists Phosphate binders Potassium deficiency Probiotic selective relaxant binding agent Urology Vaso constrictor and Vitamin deficiency.MAJOR EVENTS :2015- The Company was incorporated as a private limited company under the name “Remus PharmaceuticalsPrivate Limited”.2023- Conversion of the company from Private Limited to Public Limited Company

    REMUS PHARMACEUTICALS L Management

    NamePosition
    Mr. Swapnil Jatinbhai Shah Chairman & Wholetime Director
    Mr. Arpit Deepakkumar Shah Managing Director
    Mrs. Anar Swapnil Shah Whole Time Director
    Ms. Roma Vinodbhai Shah Whole Time Director
    Mr. Balwant Purohit Ind. Non-Executive Director
    Read More

    REMUS PHARMACEUTICALS L FAQs

    REMUS PHARMACEUTICALS L शेयर का खरीद मूल्य 2219.95 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    REMUS PHARMACEUTICALS L शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    REMUS PHARMACEUTICALS L शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 77.34 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    REMUS PHARMACEUTICALS L शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 15.04 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    REMUS PHARMACEUTICALS L शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 1.46 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    REMUS PHARMACEUTICALS L का मार्केट कैप 1282.10 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    REMUS PHARMACEUTICALS L शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 8699.00 और 1785.10 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    REMUS PHARMACEUTICALS L Share Key Metrics

    Volume
    8700.00
    Market Cap
    1282.10 CR
    LTQ@LTP
    100@2219.95
    ATP
    2215.2
    Var Margin
    53.5 %
    Circuit Range
    1740.8-2611.2
    Delivery %
    70.13 %
    Value
    1.93 CR
    ASM/GSM
    No
    Market Lot
    50